سوق مكافحة العدوى في أوروبا - اتجاهات الصناعة والتوقعات حتى عام 2030

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF EUROPE INFECTION CONTROL MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATION

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 KEY TAKEAWAYS

2.2 ARRIVING AT THE EUROPE INFECTION CONTROL MARKET SIZE

2.2.1 VENDOR POSITIONING GRID

2.2.2 TECHNOLOGY LIFE LINE CURVE

2.2.3 TRIPOD DATA VALIDATION MODEL

2.2.4 MARKET GUIDE

2.2.5 MULTIVARIATE MODELLING

2.2.6 TOP TO BOTTOM ANALYSIS

2.2.7 CHALLENGE MATRIX

2.2.8 APPLICATION COVERAGE GRID

2.2.9 STANDARDS OF MEASUREMENT

2.2.10 VENDOR SHARE ANALYSIS

2.2.11 EPIDEMIOLOGY MODELING

2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS

2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES

2.3 EUROPE INFECTION CONTROL MARKET: RESEARCH SNAPSHOT

2.4 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 CHALLENGES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

5.1 PESTEL ANALYSIS

5.2 PORTER’S FIVE FORCES MODEL

6 INDUSTRY INSIGHTS

6.1 MICRO AND MACRO ECONOMIC FACTORS

6.2 PENETRATION AND GROWTH PROSPECT MAPPING

6.3 KEY PRICING STRATEGIES

6.4 INTERVIEWS WITH SPECIALIST

6.5 ANALYIS AND RECOMMENDATION

7 INTELLECTUAL PROPERTY (IP) PORTFOLIO

7.1 PATENT QUALITY AND STRENGTH

7.2 PATENT FAMILIES

7.3 LICENSING AND COLLABORATIONS

7.4 COMPETITIVE LANDSCAPE

7.5 IP STRATEGY AND MANAGEMENT

7.6 OTHER

8 COST ANALYSIS BREAKDOWN

9 TECHNONLOGY ROADMAP

10 INNOVATION TRACKER AND STRATEGIC ANALYSIS

10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS

10.1.1 JOINT VENTURES

10.1.2 MERGERS AND ACQUISITIONS

10.1.3 LICENSING AND PARTNERSHIP

10.1.4 TECHNOLOGY COLLABORATIONS

10.1.5 STRATEGIC DIVESTMENTS

10.2 NUMBER OF PRODUCTS IN DEVELOPMENT

10.3 STAGE OF DEVELOPMENT

10.4 TIMELINES AND MILESTONES

10.5 INNOVATION STRATEGIES AND METHODOLOGIES

10.6 RISK ASSESSMENT AND MITIGATION

10.7 FUTURE OUTLOOK

11 REGULATORY COMPLIANCE

11.1 REGULATORY AUTHORITIES

11.2 REGULATORY CLASSIFICATIONS

11.2.1 CLASS I

11.2.2 CLASS II

11.2.3 CLASS III

11.3 REGULATORY SUBMISSIONS

11.4 INTERNATIONAL HARMONIZATION

11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS

11.6 REGULATORY CHALLENGES AND STRATEGIES

12 REIMBURSEMENT FRAMEWORK

13 OPPUTUNITY MAP ANALYSIS

14 VALUE CHAIN ANALYSIS

15 HEALTHCARE ECONOMY

15.1 HEALTHCARE EXPENDITURE

15.2 CAPITAL EXPENDITURE

15.3 CAPEX TRENDS

15.4 CAPEX ALLOCATION

15.5 FUNDING SOURCES

15.6 INDUSTRY BENCHMARKS

15.7 GDP RATION IN OVERALL GDP

15.8 HEALTHCARE SYSTEM STRUCTURE

15.9 GOVERNMENT POLICIES

15.1 ECONOMIC DEVELOPMENT

16 EUROPE INFECTION CONTROL MARKET, BY PRODUCT AND SERVICE

16.1 OVERVIEW

16.2 PRODUCTS

16.2.1 STERILIZATION PRODUCTS

16.2.1.1. STERILIZATION EQUIPMENT

16.2.1.1.1. HEAT STERILIZATION EQUIPMENT

16.2.1.1.1.1 MOIST HEAT STERILIZERS

16.2.1.1.1.1.1. MARKET SHARE (USD)

16.2.1.1.1.1.2. MARKET VOLUME (UNIT)

16.2.1.1.1.1.3. AVERAGE SELLING PRICE (USD)

16.2.1.1.1.2 DRY HEAT STERILIZERS

16.2.1.1.2. LOW TEMPERATURE STERILIZATION

16.2.1.1.2.1 HYDROGEN PEROXIDE STERILIZATION

16.2.1.1.2.2 ETHYLENE OXIDE STERILIZATION (ETO)

16.2.1.1.2.3 FORMALDEHYDE STERILIZATION

16.2.1.1.2.4 OTHER LOW-TEMPERATURE STERILIZATION

16.2.1.1.3. RADIATION STERILIZATION

16.2.1.1.4. FILTRATION STERILIZATION

16.2.1.1.5. OTHER EQUIPMENT

16.2.1.2. CONSUMABLES AND ACCESSORIES

16.2.1.2.1. STERILIZATION INDICATORS

16.2.1.2.2. CHEMICAL INDICATORS

16.2.1.2.3. BIOLOGICAL INDICATORS

16.2.1.2.4. PACKAGING ACCESSORIES

16.2.1.2.5. OTHERS

16.2.2 CLEANING AND DISINFECTION PRODUCTS

16.2.2.1. DISINFECTANTS

16.2.2.1.1. BY PRODUCT TYPE

16.2.2.1.1.1 HAND DISINFECTANTS

16.2.2.1.1.1.1. BY TYPE

A. ALCOHOL BASED

I. ETHANOL (ETHYL ALCOHOL)

II. ISOPROPYL ALCOHOL (ISOPROPANOL OR 2-PROPANOL)

III. OTHERS

B. ALCOHOL FREE

I. CHLORHEXIDINE

II. CHLOROXYLENOL

III. HYDROXYACETOPHENONE

IV. IODINE

V. TRICLOSAN

VI. OTHERS

16.2.2.1.1.1.2. BY DOSAGE

A. FOAM

B. GEL

C. LIQUID

D. WIPES

E. OTHERS

16.2.2.1.1.1.3. BY EPA CLASSIFICATION

A. LOW-LEVEL DISINFECTANTS

I. QUATERNARY AMMONIUM COMPOUNDS

II. IODOPHORS

III. PHENOLICS

B. INTERMEDIATE-LEVEL DISINFECTANTS

I. PHENOLS

II. CHLORINE COMPOUNDS

III. OTHERS

C. HIGH-LEVEL DISINFECTANTS

I. CHLORHEXIDINE

II. CHLOROXYLENOL

III. SUPEROXIDIZED WATER

IV. OTHERS

16.2.2.1.1.2 SURFACE DISINFECTANTS

16.2.2.1.1.2.1. ALCOHOL BASED

A. ETHANOL (ETHYL ALCOHOL)

B. ISOPROPYL ALCOHOL (ISOPROPANOL OR 2-PROPANOL)

16.2.2.1.1.2.2. ALCOHOL FREE

A. CHLORHEXIDINE

B. CHLOROXYLENOL

C. HYDROXYACETOPHENONE

D. IODINE

E. TRICLOSAN

F. OTHERS

16.2.2.1.1.2.3. BY DOSAGE

A. FOAM

B. GEL

C. LIQUID

D. WIPES

E. OTHERS

16.2.2.1.1.2.4. BY EPA CLASSIFICATION

A. LOW-LEVEL DISINFECTANTS

I. QUATERNARY AMMONIUM COMPOUNDS

II. IODOPHORS

III. PHENOLICS

B. INTERMEDIATE-LEVEL DISINFECTANTS

I. PHENOLS

II. CHLORINE COMPOUNDS

III. OTHERS

C. HIGH-LEVEL DISINFECTANTS

I. CHLORHEXIDINE

II. CHLOROXYLENOL

III. SUPEROXIDIZED WATER

IV. OTHERS

16.2.2.1.1.3 SKIN DISINFECTANTS

16.2.2.1.1.3.1. ALCOHOL BASED

16.2.2.1.1.3.2. ETHANOL (ETHYL ALCOHOL)

16.2.2.1.1.3.3. ISOPROPYL ALCOHOL (ISOPROPANOL OR 2-PROPANOL)

A. ALCOHOL FREE

I. CHLORHEXIDINE

II. CHLOROXYLENOL

III. HYDROXYACETOPHENONE

IV. IODINE

V. TRICLOSAN

VI. OTHERS

16.2.2.1.1.3.4. BY DOSAGE

A. FOAM

B. GEL

C. LIQUID

D. WIPES

E. OTHERS

16.2.2.1.1.3.5. BY EPA CLASSIFICATION

A. LOW-LEVEL DISINFECTANTS

I. QUATERNARY AMMONIUM COMPOUNDS

II. IODOPHORS

III. PHENOLICS

B. INTERMEDIATE-LEVEL DISINFECTANTS

I. PHENOLS

II. CHLORINE COMPOUNDS

III. OTHERS

C. HIGH-LEVEL DISINFECTANTS

I. CHLORHEXIDINE

II. CHLOROXYLENOL

III. SUPEROXIDIZED WATER

IV. OTHERS

16.2.2.1.1.4 INSTRUMENT DISINFECTANTS

A. ALCOHOL BASED

I. ETHANOL (ETHYL ALCOHOL)

II. ISOPROPYL ALCOHOL (ISOPROPANOL OR 2-PROPANOL)

B. ALCOHOL FREE

I. CHLORHEXIDINE

II. CHLOROXYLENOL

III. HYDROXYACETOPHENONE

IV. IODINE

V. TRICLOSAN

VI. OTHERS

16.2.2.1.1.4.2. BY DOSAGE

A. FOAM

B. GEL

C. LIQUID

D. WIPES

E. OTHERS

16.2.2.1.1.4.3. BY EPA CLASSIFICATION

A. LOW-LEVEL DISINFECTANTS

I. QUATERNARY AMMONIUM COMPOUNDS

II. IODOPHORS

III. PHENOLICS

B. INTERMEDIATE-LEVEL DISINFECTANTS

I. PHENOLS

II. CHLORINE COMPOUNDS

III. OTHERS

C. HIGH-LEVEL DISINFECTANTS

I. CHLORHEXIDINE

II. CHLOROXYLENOL

III. SUPEROXIDIZED WATER

IV. OTHERS

16.2.2.2. CLEANING AND DISINFECTION EQUIPMENT

16.2.2.2.1. WASHER DISINFECTORS

16.2.2.2.1.1 SINGLE-CHAMBER WASHERS

16.2.2.2.1.2 MULTI-CHAMBER WASHERS

16.2.2.2.1.3 GENERATION WASHER/DISINFECTORS

16.2.2.2.2. FLUSHER DISINFECTORS

16.2.2.2.2.1 FRONT LOADING

16.2.2.2.2.2 TOP LOADING

16.2.2.2.3. UV-RAY DISINFECTORS

16.2.2.2.3.1 BY TYPE OF RAYS

16.2.2.2.3.1.1. UV- RAY A

16.2.2.2.3.1.2. UV-RAY B

16.2.2.2.3.2 BY TYPE

16.2.2.2.3.2.1. FLOOR STANDING

16.2.2.2.3.2.2. BENCH TYPE

16.2.2.2.4. ULTRASONIC CLEANERS

16.2.2.2.4.1 BY TYPE

16.2.2.2.4.1.1. EQUIPMENTS

16.2.2.2.4.1.2. VIALS

16.2.2.2.4.1.3. BOTTLES

16.2.2.2.4.1.4. SYRINGES

16.2.2.2.4.2 BY ACCESSORIES

16.2.2.2.4.2.1. SINK

16.2.2.2.4.2.2. CLEANSER

16.2.2.2.5. OTHER CLEANING AND DISINFECTION EQUIPMENT

16.2.2.3. LUBRICANTS AND CLEANING SOLUTIONS

16.2.2.3.1. HYPOCHLORITE

16.2.2.3.2. ALCOHOLS

16.2.2.3.3. CHLORINE DIOXIDE

16.2.2.3.4. HYDROGEN PEROXIDE & PERACETIC ACID

16.2.2.3.5. IODOPHOR DISINFECTANT

16.2.2.3.6. QUATERNARY AMMONIUM COMPOUNDS

16.2.2.4. DISINFECTION AND CLEANING ACCESSORIES

16.2.2.4.1. CLEANING TROLLEYS

16.2.2.4.2. CLEANING STATIONS

16.2.3 PERSONAL PROTECTIVE BARRIERS

16.2.3.1. MEDICAL NONWOVENS

16.2.3.1.1. SURGICAL DRAPES

16.2.3.1.1.1 GENERAL SURGERY

16.2.3.1.1.2 ORTHOPEDIC SURGERY

16.2.3.1.1.3 CARDIAC SURGERY

16.2.3.1.1.4 FOR GYNECOLOGICAL SURGERY

16.2.3.1.1.5 UROLOGIC SURGERY

16.2.3.1.1.6 ANGIOGRAPHY

16.2.3.1.1.7 DENTAL SURGERY

16.2.3.1.1.8 CRANIOTOMY

16.2.3.1.1.9 OPHTHALMIC SURGERY

16.2.3.1.1.10 ENT SURGERY

16.2.3.1.1.11 OTHERS

16.2.3.1.2. SURGICAL GOWNS

16.2.3.1.2.1 BY USE

16.2.3.1.2.1.1. HEALTHCARE STAFF

16.2.3.1.2.1.2. PATIENT / VISITOR

16.2.3.1.2.1.3. LABORATORY STAFF

16.2.3.1.2.1.4. OTHERS

16.2.3.1.2.2 BY MATERIAL

16.2.3.1.2.2.1. POLYPROPYLENE

16.2.3.1.2.2.2. POLYETHYLENE

16.2.3.1.2.2.3. POLYESTER

16.2.3.1.2.2.4. COTTON

16.2.3.1.2.2.5. VISCOSE

16.2.3.1.2.2.6. OTHERS

16.2.3.1.3. FACE MASKS

16.2.3.1.3.1 FACIAL VENTILATION MASKS

16.2.3.1.3.2 FACIAL LARYNGEAL MASKS

16.2.3.1.3.3 HALF-MASKS FACE-SHIELDS

16.2.3.1.3.4 FACIAL ANESTHESIA MASKS

16.2.3.1.3.5 FACIAL NEBULIZATION MASKS

16.2.3.1.3.6 FACIAL RESUSCITATION MASKS

16.2.3.1.3.7 OTHERS

16.2.3.2. FACE SHIELDS

16.2.3.2.1. FULL FACE

16.2.3.2.2. HALF MASK

16.2.3.3. GOGGLES

16.2.3.3.1. SAFETY GLASSES

16.2.3.3.2. VIRTUAL REALITY GOGGLES

16.2.3.3.3. FRENZEL GOGGLES

16.2.3.4. OTHERS

16.2.4 ENDOSCOPE REPROCESSING PRODUCTS

16.2.4.1. ENDOSCOPE REPROCESSING

16.2.4.1.1. ELECTRODES

16.2.4.1.2. STORAGE DEVICES

16.2.4.1.3. CONNECTORS

16.2.4.1.4. OTHERS

16.2.4.2. ENDOSCOPE REPROCESSING EQUIPMENT

16.2.4.2.1. AUTOMATED ENDOSCOPE REPROCESSORS

16.2.4.2.2. ENDOSCOPE TRACKING SYSTEMS

16.2.4.2.3. OTHER ENDOSCOPE REPROCESSING PRODUCTS

16.2.5 CLEANERS & DETERGENTS

16.2.5.1. CLEANERS

16.2.5.1.1. LIQUID SOLUTIONS

16.2.5.1.2. FOAM-BASED CLEANERS

16.2.5.1.3. GEL-BASED CLEANERS

16.2.5.2. DETERGENTS

16.2.5.2.1. ENZYMATIC DETERGENTS

16.2.5.2.2. NEUTRAL DETERGENTS

16.2.5.2.3. ACIDIC DETERGENTS

16.2.5.2.4. ALKALINE DETERGENTS

16.2.6 DISINFECTANT SPRAYS

16.2.6.1. FLAVOURED

16.2.6.2. NON-FLAVOURED

16.2.7 OTHER INFECTION CONTROL PRODUCTS

16.3 SERVICES

16.3.1 CONTRACT SERVICES

16.3.2 INHOUSE SERVICES

17 EUROPE INFECTION CONTROL MARKET, BY APPLICATION

17.1 OVERVIEW

17.2 SURGICAL INSTRUMENTS

17.3 ENDOSCOPES

17.4 ULTRASOUND PROBES

17.5 OTHERS

18 EUROPE INFECTION CONTROL MARKET, BY END USER

18.1 OVERVIEW

18.2 CLINICS

18.3 HOSPITALS

18.3.1 BY FACILITY

18.3.1.1. CSSD

18.3.1.2. PATIENT ROOM

18.3.1.3. OPERATING ROOM

18.3.1.4. OTHERS

18.3.2 BY TYPE

18.3.2.1. PUBLIC

18.3.2.2. PRIVATE

18.3.3 BY LEVEL

18.3.3.1. TIER 1

18.3.3.2. TIER 2

18.3.3.3. TIER 3

18.4 MEDICAL DEVICE COMPANIES

18.5 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES

18.6 RESEARCH LABORA

18.7 DIAGNOSTIC LABORATORIES

18.8 OTHERS

19 EUROPE INFECTION CONTROL MARKET, BY DISTRIBUTION CHANNEL

19.1 OVERVIEW

19.2 DIRECT TENDER

19.3 RETAIL SALES

19.3.1 OFFLINE

19.3.2 ONLINE

19.4 OTHERS

20 EUROPE INFECTION CONTROL MARKET, COMPANY LANDSCAPE

20.1 COMPANY SHARE ANALYSIS: EUROPE

20.2 MERGERS & ACQUISITIONS

20.3 NEW PRODUCT DEVELOPMENT & APPROVALS

20.4 EXPANSIONS

20.5 REGULATORY CHANGES

20.6 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

21 EUROPE INFECTION CONTROL MARKET, BY REGION

21.1 EUROPE INFECTION CONTROL MARKET (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

21.1.1 EUROPE

21.1.1.1. GERMANY

21.1.1.2. FRANCE

21.1.1.3. U.K.

21.1.1.4. ITALY

21.1.1.5. SPAIN

21.1.1.6. RUSSIA

21.1.1.7. TURKEY

21.1.1.8. BELGIUM

21.1.1.9. NETHERLANDS

21.1.1.10. SWITZERLAND

21.1.1.11. REST OF EUROPE

21.1.2 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

22 EUROPE INFECTION CONTROL MARKET, SWOT & DBMR ANALYSIS

23 EUROPE INFECTION CONTROL MARKET, COMPANY PROFILE

23.1 3M

23.1.1 COMPANY OVERVIEW

23.1.2 REVENUE ANALYSIS

23.1.3 GEOGRAPHIC PRESENCE

23.1.4 PRODUCT PORTFOLIO

23.1.5 RECENT DEVELOPMENTS

23.2 ASP INTERNATIONAL GMBH

23.2.1 COMPANY OVERVIEW

23.2.2 REVENUE ANALYSIS

23.2.3 GEOGRAPHIC PRESENCE

23.2.4 PRODUCT PORTFOLIO

23.2.5 RECENT DEVELOPMENTS

23.3 SOTERA HEALTH

23.3.1 COMPANY OVERVIEW

23.3.2 REVENUE ANALYSIS

23.3.3 GEOGRAPHIC PRESENCE

23.3.4 PRODUCT PORTFOLIO

23.3.5 RECENT DEVELOPMENTS

23.4 THE CLOROX COMPANY.

23.4.1 COMPANY OVERVIEW

23.4.2 REVENUE ANALYSIS

23.4.3 GEOGRAPHIC PRESENCE

23.4.4 PRODUCT PORTFOLIO

23.4.5 RECENT DEVELOPMENTS

23.5 TERRAGENE

23.5.1 COMPANY OVERVIEW

23.5.2 REVENUE ANALYSIS

23.5.3 GEOGRAPHIC PRESENCE

23.5.4 PRODUCT PORTFOLIO

23.5.5 RECENT DEVELOPMENTS

23.6 CISA

23.6.1 COMPANY OVERVIEW

23.6.2 REVENUE ANALYSIS

23.6.3 GEOGRAPHIC PRESENCE

23.6.4 PRODUCT PORTFOLIO

23.6.5 RECENT DEVELOPMENTS

23.7 SCICAN LTD. (COLTENE)

23.7.1 COMPANY OVERVIEW

23.7.2 REVENUE ANALYSIS

23.7.3 GEOGRAPHIC PRESENCE

23.7.4 PRODUCT PORTFOLIO

23.7.5 RECENT DEVELOPMENTS

23.8 OLYMPUS CORPORATION

23.8.1 COMPANY OVERVIEW

23.8.2 REVENUE ANALYSIS

23.8.3 GEOGRAPHIC PRESENCE

23.8.4 PRODUCT PORTFOLIO

23.8.5 RECENT DEVELOPMENTS

23.9 B. BRAUN SE

23.9.1 COMPANY OVERVIEW

23.9.2 REVENUE ANALYSIS

23.9.3 GEOGRAPHIC PRESENCE

23.9.4 PRODUCT PORTFOLIO

23.9.5 RECENT DEVELOPMENTS

23.1 STRYKER

23.10.1 COMPANY OVERVIEW

23.10.2 REVENUE ANALYSIS

23.10.3 GEOGRAPHIC PRESENCE

23.10.4 PRODUCT PORTFOLIO

23.10.5 RECENT DEVELOPMENTS

23.11 CARDINAL HEALTH

23.11.1 COMPANY OVERVIEW

23.11.2 REVENUE ANALYSIS

23.11.3 GEOGRAPHIC PRESENCE

23.11.4 PRODUCT PORTFOLIO

23.11.5 RECENT DEVELOPMENTS

23.12 ZIMMER BIOMET

23.12.1 COMPANY OVERVIEW

23.12.2 REVENUE ANALYSIS

23.12.3 GEOGRAPHIC PRESENCE

23.12.4 PRODUCT PORTFOLIO

23.12.5 RECENT DEVELOPMENTS

23.13 STERIS PLC.

23.13.1 COMPANY OVERVIEW

23.13.2 REVENUE ANALYSIS

23.13.3 GEOGRAPHIC PRESENCE

23.13.4 PRODUCT PORTFOLIO

23.13.5 RECENT DEVELOPMENTS

23.14 GETINGE AB

23.14.1 COMPANY OVERVIEW

23.14.2 REVENUE ANALYSIS

23.14.3 GEOGRAPHIC PRESENCE

23.14.4 PRODUCT PORTFOLIO

23.14.5 RECENT DEVELOPMENTS

23.15 ECOLAB

23.15.1 COMPANY OVERVIEW

23.15.2 REVENUE ANALYSIS

23.15.3 GEOGRAPHIC PRESENCE

23.15.4 PRODUCT PORTFOLIO

23.15.5 RECENT DEVELOPMENTS

23.16 MATACHANA GROUP

23.16.1 COMPANY OVERVIEW

23.16.2 REVENUE ANALYSIS

23.16.3 GEOGRAPHIC PRESENCE

23.16.4 PRODUCT PORTFOLIO

23.16.5 RECENT DEVELOPMENTS

23.17 MMM GROUP

23.17.1 COMPANY OVERVIEW

23.17.2 REVENUE ANALYSIS

23.17.3 GEOGRAPHIC PRESENCE

23.17.4 PRODUCT PORTFOLIO

23.17.5 RECENT DEVELOPMENTS

23.18 BELIMED AG (METALL ZUG)

23.18.1 COMPANY OVERVIEW

23.18.2 REVENUE ANALYSIS

23.18.3 GEOGRAPHIC PRESENCE

23.18.4 PRODUCT PORTFOLIO

23.18.5 RECENT DEVELOPMENTS

23.19 METREX RESEARCH, LLC.

23.19.1 COMPANY OVERVIEW

23.19.2 REVENUE ANALYSIS

23.19.3 GEOGRAPHIC PRESENCE

23.19.4 PRODUCT PORTFOLIO

23.19.5 RECENT DEVELOPMENTS

23.2 RECKITT BENCKISER GROUP PLC

23.20.1 COMPANY OVERVIEW

23.20.2 REVENUE ANALYSIS

23.20.3 GEOGRAPHIC PRESENCE

23.20.4 PRODUCT PORTFOLIO

23.20.5 RECENT DEVELOPMENTS

23.21 STEELCO S.P.A. (MIELE)

23.21.1 COMPANY OVERVIEW

23.21.2 REVENUE ANALYSIS

23.21.3 GEOGRAPHIC PRESENCE

23.21.4 PRODUCT PORTFOLIO

23.21.5 RECENT DEVELOPMENTS

23.22 PAL INTERNATIONAL

23.22.1 COMPANY OVERVIEW

23.22.2 REVENUE ANALYSIS

23.22.3 GEOGRAPHIC PRESENCE

23.22.4 PRODUCT PORTFOLIO

23.22.5 RECENT DEVELOPMENTS

23.22.6 COMPANY OVERVIEW

23.22.7 REVENUE ANALYSIS

23.22.8 GEOGRAPHIC PRESENCE

23.22.9 PRODUCT PORTFOLIO

23.22.10 RECENT DEVELOPMENTS

23.23 MELAG MEDIZINTECHNIK GMBH & CO. KG

23.23.1 COMPANY OVERVIEW

23.23.2 REVENUE ANALYSIS

23.23.3 GEOGRAPHIC PRESENCE

23.23.4 PRODUCT PORTFOLIO

23.23.5 RECENT DEVELOPMENTS

23.24 CONTEC, INC.

23.24.1 COMPANY OVERVIEW

23.24.2 REVENUE ANALYSIS

23.24.3 GEOGRAPHIC PRESENCE

23.24.4 PRODUCT PORTFOLIO

23.24.5 RECENT DEVELOPMENTS

23.25 MEDALKAN

23.25.1 COMPANY OVERVIEW

23.25.2 REVENUE ANALYSIS

23.25.3 GEOGRAPHIC PRESENCE

23.25.4 PRODUCT PORTFOLIO

23.25.5 RECENT DEVELOPMENTS

23.26 C.B.M. S.R.L. MEDICAL EQUIPEMENT

23.26.1 COMPANY OVERVIEW

23.26.2 REVENUE ANALYSIS

23.26.3 GEOGRAPHIC PRESENCE

23.26.4 PRODUCT PORTFOLIO

23.26.5 RECENT DEVELOPMENTS

NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST

24 RELATED REPORTS

25 CONCLUSION

26 QUESTIONNAIRE

27 ABOUT DATA BRIDGE MARKET RESEARCH